story of the week
Similar Outcomes With Infliximab Biosimilar and Infliximab Originator for Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The Infliximab Biosimilar in the Treatment of Moderate to Severe Plaque Psoriasis
J Am Acad Dermatol 2016 Jul 27;[EPub Ahead of Print], P Dapavo, I Vujic, MT Fierro, P Quaglino, M SanlorenzoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.